MeiraGTx Holdings
MGTX
10.56
-0.26
-2.40%
MeiraGTx Holdings
US · MGTX
#3220 by market cap
Listed 2018
10.56
-0.26
-2.40%
Live - 5344 symbols - heartbeat 496s ago
· 2026-10-08 10:00
Pre-market
10.70
-1.11%
After-hours
10.82
0.00%
- Market cap
- 1.01B
- P/E (TTM)i
- 12.14
- P/Bi
- 4.70
- EPSi
- -1.42
- Div yieldi
- 0.00%
- 52W posi
- 45%
Reader sentiment
Are you bullish or bearish on MGTX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 3 in the most recent period (2026/Q3).
- Total institutional ownership fell 2.1 percentage points.
Institutional ownership
- Held by institutions
- 83.93% -2.09pp
- Institutions
- 194 +3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Hedge Fund29.94%
VC/PE Fund20.37%
Mutual Fund17.12%
Public Company15.03%
Individual/Insider3.55%
Insurance Company0.80%
Private Company0.41%
Government Pension Fund0.26%
Other12.52%
Top holders as of 2026-06-30
Sanofi
12.70% · 12.20M sh
Perceptive Advisors LLC
11.23% · 10.79M sh
Rubric Capital Management LP
9.47% · 9.10M sh
Johnson & Johnson Innovation - JJDC, Inc.
6.91% · 6.64M sh
BlackRock
4.95% · 4.76M sh
Adage Capital Management, L.P.
4.58% · 4.40M sh
Opaleye Management Inc.
3.70% · 3.55M sh
Millennium Management LLC
3.09% · 2.97M sh
683 Capital Management, LLC
2.39% · 2.30M sh
Woodline Partners LP
1.56% · 1.50M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 28 buys · 21 sells
| Name | Role | Stake |
|---|---|---|
| Perceptive Advisors LLC | -- | 11.23% |
| Alexandria Forbes | Chief Executive Officer | 1.38% |
| Richard Giroux | Chief Financial Officer | 1.04% |
| Stuart Naylor | Chief Development Officer | 0.67% |
| Keith Harris | Independent Chairperson | 0.21% |
| Robert Zeldin | Chief Medical Officer | 0.18% |
| Robert Wollin | General Counsel | 0.06% |
| Neil Mendoza | Independent Director | 0.01% |
| Nicole Seligman | Independent Director | 0.01% |
| Jiuyun Yu | Independent Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-05 | Stuart Naylor | Chief Development Officer | Intent to Sell (Form 144) | -27,659 | $10.64 |
| 2026-09-22 | Alan Sebulsky | Director | Other Derivative Acquisition | +100,000 | -- |
| 2026-09-22 | Apothecary Capital LLC | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-08-17 | Alexandria Forbes | Chief Executive Officer | Automatic Disposition | -62,000 | $13.86 |
| 2026-07-20 | Richard Giroux | Chief Financial Officer | Automatic Disposition | -56,000 | $12.51 |
| 2026-07-06 | Stuart Naylor | Chief Development Officer | Automatic Disposition | -27,659 | $13.86–14.90 |
| 2026-06-24 | Alexandria Forbes | Chief Executive Officer | Other Derivative Acquisition | +980,000 | -- |
| 2026-06-24 | Richard Giroux | Chief Financial Officer | Other Derivative Acquisition | +980,000 | -- |
| 2026-06-24 | Stuart Naylor | Chief Development Officer | Other Derivative Acquisition | +70,000 | -- |
| 2026-06-24 | Robert Zeldin | Chief Medical Officer | Other Derivative Acquisition | +100,000 | -- |
| 2026-06-24 | Robert Wollin | General Counsel | Other Derivative Acquisition | +100,000 | -- |
| 2026-06-10 | Jiuyun Yu | Independent Director | Other Derivative Acquisition | +60,000 | -- |
| 2026-06-10 | Thomas Shenk | Independent Director & Member of Scientific Advisory Board | Other Derivative Acquisition | +69,662 | -- |
| 2026-06-10 | Keith Harris | Independent Chairperson | Other Derivative Acquisition | +106,441 | -- |
| 2026-06-10 | Perceptive Advisors LLC | -- | Other Derivative Acquisition | +60,000 | -- |
| 2026-06-10 | Nicole Seligman | Independent Director | Other Derivative Acquisition | +60,000 | -- |
| 2026-06-10 | Neil Mendoza | Independent Director | Other Derivative Acquisition | +66,641 | -- |
| 2026-06-10 | Ellen Hukkelhoven | Independent Director | Other Derivative Acquisition | +60,000 | -- |
| 2026-06-09 | Keith Harris | Independent Chairperson | Derivative Exercise and Retained | +75,000 | -- |
| 2026-05-18 | Alexandria Forbes | Chief Executive Officer | Automatic Disposition | -62,000 | $9.17 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 10:00:02 · For reference only, not investment advice and not tailored to your situation.